(2R)-2-(4-methyl-1,2,4-triazol-3-yl)-N-[5-(trifluoromethyl)-1,3-thiazol-2-yl]pyrrolidine-1-carboxamide
C12H13F3N6OS — CID 125138491
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-(4-methyl-1,2,4-triazol-3-yl)-N-[5-(trifluoromethyl)-1,3-thiazol-2-yl]pyrrolidine-1-carboxamide
(2R)-2-(4-methyl-1,2,4-triazol-3-yl)-N-[5-(trifluoromethyl)-1,3-thiazol-2-yl]pyrrolidine-1-carboxamide (PubChem CID 125138491) has the molecular formula C12H13F3N6OS and a molecular weight of 346.34 g/mol. Its IUPAC name is (2R)-2-(4-methyl-1,2,4-triazol-3-yl)-N-[5-(trifluoromethyl)-1,3-thiazol-2-yl]pyrrolidine-1-carboxamide.
Molecular Properties
| Compound Name | (2R)-2-(4-methyl-1,2,4-triazol-3-yl)-N-[5-(trifluoromethyl)-1,3-thiazol-2-yl]pyrrolidine-1-carboxamide |
|---|---|
| PubChem CID | 125138491 |
| Molecular Formula | C12H13F3N6OS |
| Molecular Weight | 346.34 g/mol |
| Exact Mass | 346.08 |
| IUPAC Name | (2R)-2-(4-methyl-1,2,4-triazol-3-yl)-N-[5-(trifluoromethyl)-1,3-thiazol-2-yl]pyrrolidine-1-carboxamide |
| SMILES | Cn1cnnc1[C@H]1CCCN1C(=O)Nc1ncc(C(F)(F)F)s1 |
| InChI | InChI=1S/C12H13F3N6OS/c1-20-6-17-19-9(20)7-3-2-4-21(7)11(22)18-10-16-5-8(23-10)12(13,14)15/h5-7H,2-4H2,1H3,(H,16,18,22)/t7-/m1/s1 |
| InChIKey | WIZLDDSQDKKVPU-SSDOTTSWSA-N |
| XLogP | 2.66 |
| TPSA | 75.94 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 346.34 |
| LogP ≤ 5 | 2.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 125138491 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.